array(63) { ["SERVER_SOFTWARE"]=> string(6) "Apache" ["REQUEST_URI"]=> string(43) "/instituto/idorpost_scientists/laura-testa/" ["PHP_PATH"]=> string(24) "/opt/bitnami/php/bin/php" ["FREETDSLOCALES"]=> string(0) "" ["FREETDSCONF"]=> string(0) "" ["OPENSSL_ENGINES"]=> string(31) "/opt/bitnami/common/lib/engines" ["OPENSSL_CONF"]=> string(39) "/opt/bitnami/common/openssl/openssl.cnf" ["SSL_CERT_FILE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["CURL_CA_BUNDLE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["LDAPCONF"]=> string(42) "/opt/bitnami/common/etc/openldap/ldap.conf" ["GS_LIB"]=> string(43) "/opt/bitnami/common/share/ghostscript/fonts" ["MAGICK_CODER_MODULE_PATH"]=> string(60) "/opt/bitnami/common/lib/ImageMagick-6.9.8/modules-Q16/coders" ["MAGICK_CONFIGURE_PATH"]=> string(73) "/opt/bitnami/common/lib/ImageMagick-6.9.8/config-Q16:/opt/bitnami/common/" ["MAGICK_HOME"]=> string(19) "/opt/bitnami/common" ["PATH"]=> string(260) "/opt/bitnami/apps/wordpress/bin:/opt/bitnami/varnish/bin:/opt/bitnami/sqlite/bin:/opt/bitnami/php/bin:/opt/bitnami/mysql/bin:/opt/bitnami/letsencrypt/:/opt/bitnami/apache2/bin:/opt/bitnami/common/bin:/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin" ["USER"]=> string(6) "daemon" ["HOME"]=> string(9) "/usr/sbin" ["SCRIPT_NAME"]=> string(10) "/index.php" ["QUERY_STRING"]=> string(0) "" ["REQUEST_METHOD"]=> string(3) "GET" ["SERVER_PROTOCOL"]=> string(8) "HTTP/1.0" ["GATEWAY_INTERFACE"]=> string(7) "CGI/1.1" ["REDIRECT_URL"]=> string(43) "/instituto/idorpost_scientists/laura-testa/" ["REMOTE_PORT"]=> string(5) "47816" ["SCRIPT_FILENAME"]=> string(44) "/opt/bitnami/apps/wordpress/htdocs/index.php" ["SERVER_ADMIN"]=> string(15) "[email protected]" ["CONTEXT_DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["CONTEXT_PREFIX"]=> string(0) "" ["REQUEST_SCHEME"]=> string(4) "http" ["DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["REMOTE_ADDR"]=> string(13) "18.230.191.84" ["SERVER_PORT"]=> string(2) "80" ["SERVER_ADDR"]=> string(11) "172.26.1.14" ["SERVER_NAME"]=> string(13) "54.225.48.228" ["SERVER_SIGNATURE"]=> string(0) "" ["LD_LIBRARY_PATH"]=> string(410) "/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/varnish/lib:/opt/bitnami/varnish/lib/varnish:/opt/bitnami/varnish/lib/varnish/vmods:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/common/lib64" ["HTTP_CDN_LOOP"]=> string(10) "cloudflare" ["HTTP_CF_CONNECTING_IP"]=> string(13) "44.221.66.130" ["HTTP_ACCEPT_LANGUAGE"]=> string(14) "en-US,en;q=0.5" ["HTTP_ACCEPT"]=> string(63) "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8" ["HTTP_USER_AGENT"]=> string(40) "CCBot/2.0 (https://commoncrawl.org/faq/)" ["HTTP_CF_VISITOR"]=> string(22) "{\"scheme\":\"https\"}" ["HTTP_CF_RAY"]=> string(20) "8936180e0d85879a-GRU" ["HTTP_ACCEPT_ENCODING"]=> string(8) "gzip, br" ["HTTP_CF_IPCOUNTRY"]=> string(2) "US" ["HTTP_TRUE_CLIENT_IP"]=> string(13) "44.221.66.130" ["HTTP_X_AMZN_TRACE_ID"]=> string(40) "Root=1-666b8a4f-25087a2a00c000810065cf82" ["HTTP_X_FORWARDED_PORT"]=> string(3) "443" ["HTTP_CONNECTION"]=> string(5) "close" ["HTTP_X_FORWARDED_PROTO"]=> string(4) "http" ["HTTP_X_FORWARDED_FOR"]=> string(43) "44.221.66.130, 172.71.10.181, 10.247.46.220" ["HTTP_X_REAL_IP"]=> string(13) "10.247.46.220" ["HTTP_X_FORWARDED_HOST"]=> string(25) "www.rededorsaoluiz.com.br" ["HTTP_HOST"]=> string(13) "54.225.48.228" ["SCRIPT_URI"]=> string(63) "http://54.225.48.228/instituto/idorpost_scientists/laura-testa/" ["SCRIPT_URL"]=> string(43) "/instituto/idorpost_scientists/laura-testa/" ["REDIRECT_STATUS"]=> string(3) "200" ["REDIRECT_SCRIPT_URI"]=> string(63) "http://54.225.48.228/instituto/idorpost_scientists/laura-testa/" ["REDIRECT_SCRIPT_URL"]=> string(43) "/instituto/idorpost_scientists/laura-testa/" ["FCGI_ROLE"]=> string(9) "RESPONDER" ["PHP_SELF"]=> string(10) "/index.php" ["REQUEST_TIME_FLOAT"]=> float(1718323791.6786) ["REQUEST_TIME"]=> int(1718323791) }

Laura Testa

Laura Testa

Médica oncologista graduada pela Faculdade de Medicina da USP, com residências na mesma instituição, onde é chefe do Grupo de Oncologia Mamária (no Instituto do Câncer do Estado de São Paulo). Atua também na Oncologia D’Or em São Paulo na unidade OncoStar e como responsável técnica da Oncologia do Hospital São Luiz Itaim. Suas pesquisas têm como foco a oncologia, em particular o câncer de mama e seus tratamentos.

Palavras-chave: câncer de mama; pesquisa clínica; custo efetividade; cardiotoxicidade

PESQUISA

Residência em Oncologia Clínica pelo Instituto do Câncer do Estado de São Paulo (ICESP-HC-FMUSP) (2009 – 2012)

Residência em Clínica Médica pela Faculdade de Medicina da Universidade de São Paulo (FMUSP) (2007 – 2009)

Graduação pela Faculdade de Medicina da Universidade de São Paulo (FMUSP) (2001 – 2006)

ÁREAS DE PESQUISA

INFORMAÇÕES ADICIONAIS

Prêmios e Títulos

Membro da Sociedade Brasileira de Oncologia Clínica (SBOC)

Membro do Comitê de Tumores Mamários da SBOC

Publicações Selecionadas

Testa L, Mano M, Arai RJ, Bonadio RC, Serrano SV, Zorzetto MMC, Crocamo S, Smaletz O, Freitas-Junior R, Hoff PM. Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy. Clinics (Sao Paulo). 2021 Oct 11;76:e3146. PMID: 34644735; PMCID: PMC8478140.

Kawahara LT, Costa IBSDS, Barros CCS, Almeida GC, Bittar CS, Rizk SI, Testa L, Moniz CMV, Pereira J, Oliveira GMM, Diz MDPE, Guimarães PO, Pinto IM, Kalil Filho R, Hajjar LA, Hoff PM. Cancer and Cardiovascular Diseases during the COVID-19 Pandemic. Arq Bras Cardiol. 2020 Sep;115(3):547-557. English, Portuguese. PMID: 33027380; PMCID: PMC9363105.

Oliveira LJC, Megid TBC, Rosa DD, Magliano CADS, Assad DX, Argolo DF, Sanches SM, Testa L, Bines J, Kaliks R, Caleffi M, de Melo Gagliato D, Sahade M, Barroso-Sousa R, Corrêa TS, Shimada AK, Batista DN, Musse Gomes D, Cesca MG, Gaudêncio D, Moura LMA, de Araújo JAP, Katz A, Mano MS. Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study. Ther Adv Med Oncol. 2022 Dec 26;14:17588359221141760. PMID: 36601632; PMCID: PMC9806428.

Winer EP, Lipatov O, Im SA, Goncalves A, Muñoz-Couselo E, Lee KS, Schmid P, Tamura K, Testa L, Witzel I, Ohtani S, Turner N, Zambelli S, Harbeck N, Andre F, Dent R, Zhou X, Karantza V, Mejia J, Cortes J; KEYNOTE-119 investigators. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Apr;22(4):499-511. Epub 2021 Mar 4. PMID: 33676601.

Martin M, Hegg R, Kim SB, Schenker M, Grecea D, Garcia-Saenz JA, Papazisis K, Ouyang Q, Lacko A, Oksuzoglu B, Reeves J, Okera M, Testa L, Shimizu C, Denduluri N, Adamchuk H, Dakhil S, Wei R, Forrester T, Fernandez MM, Zimmermann A, Headley D, Johnston SRD. Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial. JAMA Oncol. 2022 Aug 1;8(8):1190-1194. PMID: 35653145; PMCID: PMC9164117.

Notícias Relacionadas
Conteúdo Relacionado
Fale com a gente.